Optimising cardiac surgery outcomes in people with diabetes: the OCTOPuS pilot feasibility study
Optimising cardiac surgery outcomes in people with diabetes: the OCTOPuS pilot feasibility study
Background: surgical outcomes are worse in people with diabetes, in part, because of the effects of hyperglycaemia, obesity and other comorbidities. Two important uncertainties in the management of people with diabetes undergoing major surgery exist: (1) how to improve diabetes management prior to an elective procedure and (2) whether that improved management leads to better post-operative outcomes.
Objective: the Optimising Cardiac Surgery ouTcOmes in People with diabeteS project aimed to assess whether a pre-operative outpatient intervention delivered by a multidisciplinary specialist diabetes team could improve diabetes management and cardiac surgical outcomes for people with diabetes. Although the intervention could be applied to any surgical discipline, cardiothoracic surgery was chosen because 30–40% of those undergoing elective cardiac revascularisation have diabetes.
Methods: the project had three phases: (1) designing the intervention, (2) a pilot study of the intervention and (3) a multicentre randomised controlled study in United Kingdom cardiothoracic centres to assess whether the intervention could improve surgical outcomes. The first two phases were completed, but the COVID-19 pandemic and its subsequent effects on cardiothoracic services and research capacity in the United Kingdom meant that the randomised controlled study could not be undertaken.
Intervention development: two rapid literature reviews were undertaken to understand what factors influence surgical outcomes in people with diabetes and what interventions have previously been tested. The Optimising Cardiac Surgery ouTcOmes in People with diabeteS intervention was based on an existing nurse-led outpatient intervention, delivered in the 3 months before elective orthopaedic surgery. This intervention reduced pre-operative glycated haemoglobin and reduced length of stay. We undertook a survey of United Kingdom cardiothoracic surgeons, which found limited and inconsistent pre-operative management of people with diabetes awaiting cardiothoracic surgery. A prototype intervention was developed following discussions with relevant stakeholders.
Pilot study: the pilot feasibility study recruited 17 people with diabetes and was undertaken by the diabetes and cardiothoracic surgery departments at University Hospital Southampton NHS Foundation Trust. Biomedical data were collected at baseline and prior to surgery. We assessed how the intervention was used. In-depth qualitative interviews with participants and healthcare professionals explored perceptions and experiences of the intervention and how it might be improved. Thirteen people completed the study and underwent cardiothoracic surgery. All components of the Optimising Cardiac Surgery ouTcOmes in People with diabeteS intervention were used, but not all parts were used for all participants. Minor changes were made to the intervention following feedback from the participants and healthcare professionals. Median (interquartile range) glycated haemoglobin fell 10 mmol/mol (3–13) prior to surgery. The median duration of admission for surgery was 7 (interquartile range 6–9) days.
Multicentre randomised controlled study of the United Kingdom cardiothoracic centres: we could not proceed to the multicentre randomised controlled study because of the impact of COVID-19 on the delivery of cardiothoracic surgical services and research capacity.
Conclusion: there remains an urgent need to improve the surgical outcomes for people with diabetes. This project demonstrated that it is possible to develop a clinical pathway to improve diabetes management prior to admission.
Limitations: we could not test the effectiveness of the intervention in a multicentre randomised controlled trial because of the COVID-19 pandemic.
Future work: the intervention is available for future research or clinical implementation.
diabetes, feasibility, pilot, surgery
Holt, Richard I.G.
d54202e1-fcf6-4a17-a320-9f32d7024393
Barnard-Kelly, Katharine
3eaaad91-92b9-40f2-bd49-c325466e9c83
Patel, Mayank
8259f48b-31e3-439a-9e96-f8e095b8df72
Newland-Jones, Philip
d301f33d-5b4e-4b89-ad79-18973323fbef
Luthra, Suvitesh
b00426c0-a2eb-42ec-bf8a-6e195f58a2be
Picot, Jo
324d6f20-a105-49fd-9fb0-88791be84ada
Partridge, Helen
1f49b608-a6c3-4349-819e-789326674973
Cook, Andrew
ab9c7bb3-974a-4db9-b3c2-9942988005d5
14 August 2025
Holt, Richard I.G.
d54202e1-fcf6-4a17-a320-9f32d7024393
Barnard-Kelly, Katharine
3eaaad91-92b9-40f2-bd49-c325466e9c83
Patel, Mayank
8259f48b-31e3-439a-9e96-f8e095b8df72
Newland-Jones, Philip
d301f33d-5b4e-4b89-ad79-18973323fbef
Luthra, Suvitesh
b00426c0-a2eb-42ec-bf8a-6e195f58a2be
Picot, Jo
324d6f20-a105-49fd-9fb0-88791be84ada
Partridge, Helen
1f49b608-a6c3-4349-819e-789326674973
Cook, Andrew
ab9c7bb3-974a-4db9-b3c2-9942988005d5
Holt, Richard I.G., Barnard-Kelly, Katharine, Patel, Mayank, Newland-Jones, Philip, Luthra, Suvitesh, Picot, Jo, Partridge, Helen and Cook, Andrew
,
OCTOPuS Study Group
(2025)
Optimising cardiac surgery outcomes in people with diabetes: the OCTOPuS pilot feasibility study.
Health technology assessment (Winchester, England), 29 (39).
(doi:10.3310/POYW3311).
Abstract
Background: surgical outcomes are worse in people with diabetes, in part, because of the effects of hyperglycaemia, obesity and other comorbidities. Two important uncertainties in the management of people with diabetes undergoing major surgery exist: (1) how to improve diabetes management prior to an elective procedure and (2) whether that improved management leads to better post-operative outcomes.
Objective: the Optimising Cardiac Surgery ouTcOmes in People with diabeteS project aimed to assess whether a pre-operative outpatient intervention delivered by a multidisciplinary specialist diabetes team could improve diabetes management and cardiac surgical outcomes for people with diabetes. Although the intervention could be applied to any surgical discipline, cardiothoracic surgery was chosen because 30–40% of those undergoing elective cardiac revascularisation have diabetes.
Methods: the project had three phases: (1) designing the intervention, (2) a pilot study of the intervention and (3) a multicentre randomised controlled study in United Kingdom cardiothoracic centres to assess whether the intervention could improve surgical outcomes. The first two phases were completed, but the COVID-19 pandemic and its subsequent effects on cardiothoracic services and research capacity in the United Kingdom meant that the randomised controlled study could not be undertaken.
Intervention development: two rapid literature reviews were undertaken to understand what factors influence surgical outcomes in people with diabetes and what interventions have previously been tested. The Optimising Cardiac Surgery ouTcOmes in People with diabeteS intervention was based on an existing nurse-led outpatient intervention, delivered in the 3 months before elective orthopaedic surgery. This intervention reduced pre-operative glycated haemoglobin and reduced length of stay. We undertook a survey of United Kingdom cardiothoracic surgeons, which found limited and inconsistent pre-operative management of people with diabetes awaiting cardiothoracic surgery. A prototype intervention was developed following discussions with relevant stakeholders.
Pilot study: the pilot feasibility study recruited 17 people with diabetes and was undertaken by the diabetes and cardiothoracic surgery departments at University Hospital Southampton NHS Foundation Trust. Biomedical data were collected at baseline and prior to surgery. We assessed how the intervention was used. In-depth qualitative interviews with participants and healthcare professionals explored perceptions and experiences of the intervention and how it might be improved. Thirteen people completed the study and underwent cardiothoracic surgery. All components of the Optimising Cardiac Surgery ouTcOmes in People with diabeteS intervention were used, but not all parts were used for all participants. Minor changes were made to the intervention following feedback from the participants and healthcare professionals. Median (interquartile range) glycated haemoglobin fell 10 mmol/mol (3–13) prior to surgery. The median duration of admission for surgery was 7 (interquartile range 6–9) days.
Multicentre randomised controlled study of the United Kingdom cardiothoracic centres: we could not proceed to the multicentre randomised controlled study because of the impact of COVID-19 on the delivery of cardiothoracic surgical services and research capacity.
Conclusion: there remains an urgent need to improve the surgical outcomes for people with diabetes. This project demonstrated that it is possible to develop a clinical pathway to improve diabetes management prior to admission.
Limitations: we could not test the effectiveness of the intervention in a multicentre randomised controlled trial because of the COVID-19 pandemic.
Future work: the intervention is available for future research or clinical implementation.
Text
3048638
- Version of Record
More information
Published date: 14 August 2025
Keywords:
diabetes, feasibility, pilot, surgery
Identifiers
Local EPrints ID: 505425
URI: http://eprints.soton.ac.uk/id/eprint/505425
ISSN: 1366-5278
PURE UUID: cd23c31a-0f02-4c69-8caf-d69810831ef5
Catalogue record
Date deposited: 08 Oct 2025 16:33
Last modified: 09 Oct 2025 01:45
Export record
Altmetrics
Contributors
Author:
Katharine Barnard-Kelly
Author:
Mayank Patel
Author:
Philip Newland-Jones
Author:
Suvitesh Luthra
Author:
Helen Partridge
Corporate Author: OCTOPuS Study Group
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics